UroGen Pharma Ltd.
NASDAQUroGen Pharma heads into its June 22 earnings report with a stock that has lost nearly 10% on the week — yet short sellers have been quietly covering rather than pressing their bets. The week's central tension is that divergence: a sharp price decline paired with shorts pulling back, borrow conditions that remain almost comically loose, and a Street that has been lifting targets…
Snapshot as of 22 Jun 2026
UroGen Pharma heads into its June 22 earnings report with a stock that has lost nearly 10% on the week — yet short sellers have been quietly covering rather than pressing their bets. The week's central tension is that…
UroGen Pharma heads into its May 11 earnings report with short sellers pulling back even as the stock's structural bear case remains firmly intact. The most striking feature of the past month is the divergence between…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for URGN — free to start on ORTEX.
Sign up for free →Open URGN on ORTEX